Vineet Laboratories Limited VINEETLAB.NS Open Vineet Laboratories Limited in new tab
Vineet Laboratories Limited Analysis (VINEETLAB.NS)
Is Vineet Laboratories Limited a good investment? Vineet Laboratories Limited (VINEETLAB.NS) is currently trading at 39.59 INR.
Investor FAQ
Does Vineet Laboratories Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Vineet Laboratories Limited?
Vineet Laboratories Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2022 | 1.00 INR |
| Oct. 28, 2022 | 1.0000 |
Yearly aggregated dividends
Dividends
Historical Split Corporate Actions
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion